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Abstract
Background: Hepatic fibrosis and its end point; cirrhosis, are the major cause of liver failure and death in patients
with chronic liver disease. Therefore, the need for an effective treatment is evident. This study was designed to
assess the potential effects of aqueous extract of date fruits, either flesh (DFE) or pits (DPE), on oxidative DNA
damage and liver inflammation induced by carbon tetrachloride (CCl4) and whether they are related to inhibition of
nuclear factor-κB pathway. In addition, the fibrolytic potential was evaluated via measuring matrix
metalloproteinase-9 and tissue inhibitor of metalloproteinases −1 and −2.
Methods: Rats were divided into the following groups: normal control, model control (CCl4 only), CCl4 + DFE, CCl4 +
DPE and CCl4 + coffee. Coffee was used as a positive control. Fibrosis was induced by chronic administration of CCl4 (0.
4 ml/kg) 3× a week for 8 weeks, and rats were treated with 6 ml/kg/day of DFE or DPE for 8 weeks. Liver homogenate
was prepared for evaluation of oxidative stress, DNA damage, inflammatory and fibrolytic markers. Data are analyzed
using one-way analysis of variance followed by a Tukey-Kramer post hoc test.
Results: Both DFE and DPE significantly attenuated CCl4-induced oxidative damage as indicated by reducing lipid,
protein and DNA oxidation in addition to increasing the levels of hepatic catalase activity. Both extracts blocked the
accumulation of collagen I in the liver and ameliorated the increased expression of collagen III and α-smooth muscle
actin suggesting suppression of profibrotic response induced by CCl4. DFE and DPE also upregulated the expression of
heme oxygenase-1 and attenuated the nuclear factor-κB activation and cycloxygenase-2 expression reflecting their
anti-inflammatory potential. Additionally, both flesh and pits extracts attenuated the increase in the tissue inhibitor of
metalloproteinases −1 and −2 suggesting their fibrolytic activity.
Conclusion: Our data suggest that DFE or DPE can prevent liver fibrosis by suppressing genotoxicity and nuclear
factor-κB inflammatory pathway and by promoting collagen degradation.
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Background
Hepatic fibrosis represents a wound-healing response of
the liver to repeated injuries. It accompanied most
chronic liver diseases caused by hepatitis viruses, alcohol
abuse, metabolic or autoimmune diseases and chemical
toxicity [1]. Cirrhosis is the end point of the fibrogenic
process, and its complications- including portal hyper-
tension, liver failure, and hepatocellular carcinoma- are
the ultimate causes of death in most patients [2]. If
treated properly, hepatic fibrosis can be reversed and its
progression to irreversible cirrhosis may be prevented.
Liver fibrosis is characterized by the excessive synthesis
and deposition of extracellular matrix (ECM) components,
particularly collagens, resulting in derangement of the
hepatic architecture by forming fibrous scars, and the sub-
sequent development of nodules of regenerating hepato-
cytes. The major source of ECM accumulation following
chronic liver injury is the transformation of hepatic stel-
late cells (HSCs) from quiescent vitamin A-storing cells
into proliferative and fibrogenic myofibroblast-like pheno-
type, expressing alpha-smooth muscle actin (α-SMA), and
dramatically increase the production of collagens [1, 2].
Matrix metalloproteinases (MMPs) are a group of
zinc-dependent proteolytic enzymes that specifically pro-
mote ECM degradation [3]. Tissue inhibitors of metallo-
proteinases (TIMPs) are a group of functional peptides
blocking ECM degradation by inhibiting MMPs proteo-
lytic activity [4]. Under physiological conditions, MMPs
and TIMPs are in homeostasis and they maintain hep-
atic ECM’s stability by regulating the formation and deg-
radation. However, upon liver injury, an imbalance
between MMPs and TIMPs activities has been developed
and contribute to ECM accumulation and liver fibrosis
[5]. Studies have shown that MMPs gene therapy can
ameliorate experimental rat liver fibrosis [6, 7]. Further-
more, studies suggest that antibody and antisense oligo-
nucleotides directed to TIMP-1 attenuate rat liver
fibrosis [4]. Therefore, the interplay between MMPs and
TIMPs provides a reference point to develop therapies
for patients with ongoing fibrosis.
Collective evidences indicated that liver fibrosis incor-
porates uncontrolled inflammation as a part of its eti-
ology. Nuclear factor- kappa B (NF-κB) is a transcription
factor that serves as important regulators of the inflam-
matory response in liver fibrosis [8]. NF-κB consists of
p65 and p50 subunits of Rel protein family and is ordin-
arily retained in the cytoplasm in an inactive form. Acti-
vation of NF-κB occurs after exposure of cells to
oxidative stress and other physiological and pathological
stimuli. Activated NF-κB translocates to the nucleus,
where it regulates the expression of target genes in-
volved in HSC activation, releasing of proinflammatory
cytokines including tumor necrosis factor-alpha (TNF-
α), Interleukin-6 (IL-6), IL-1β, and other inflammatory
mediators such as cyclooxygenase-2 (COX-2) and indu-
cible nitric oxide synthase (iNOS) which are involved in
the process of fibrogenesis [9]. Some reports have indi-
cated that hepatic injury induced by ischemia-reperfusion,
alcohol, or endotoxin can be ameliorated by suppressing
NF-κB activation in the liver [8, 10]. In addition, there is
evidence showing that, competitive antagonism of NF-κB
can inhibit the inflammatory response and prevent CCl4-
induced hepatic injury and fibrosis [11]. Therefore, in the
last few years, much attention has been focused on
inhibiting NF-κB pathway as a target for prevention or
treatment of liver fibrosis.
Chemical toxicity and chronic inflammation are tightly
associated with the continuous generation of reactive oxy-
gen species (ROS) which cause various types of tissue
damage including lipid peroxidation, degradation of
proteins, strand breakage of DNA, and formation of 8-
hydroxy-2’- deoxyguanosine (8-OHdG) [12, 13]. Through
these molecular derangements, highly concentrated ROS
may give rise to parenchymal cell death, replaced by tissue
fibrosis [14]. Furthermore, accumulation of 8-OHdG in
DNA eventually brings about cellular mutagenesis and
subsequent carcinogenesis. Because the liver is an iron-
rich organ which contains 30 % of total body storage iron
[15], it is considered to be one of the most susceptible or-
gans to cellular damage or DNA mutagenesis caused by
ROS. Therefore, prevention of oxidative genotoxicity is
vital for inhibiting liver fibrosis and protection against
hepatocarcinogenesis.
Heme oxygenase-1 (HO-1), an important antioxidant en-
zyme catalyzing the rate-limiting step in heme degradation,
is one of the factors protecting against oxidative stress, in-
flammation, and metabolic dysregulation [16]. Recently, it
has been reported that HO-1 induction by hemin protects
the liver against obesity-induced metabolic dysregulation
by reducing hepatic oxidative stress and reducing adipose
inflammation [16]. In addition, up-regulation of HO-1 has
been shown to protect liver cells from ischemia/reperfu-
sion injury via antioxidant, anti-inflammatory and antia-
poptotic mechanisms [17–19]. Formerly, Tsui et al. [20]
suggested the induction of HO-1 in HSCs as a new ap-
proach for the treatment of liver fibrosis. Therefore and ac-
cording to these findings, we hypothesized that dietary
factors that promote HO-1 induction might help to protect
liver from carbon tetrachloride (CCl4)-induced oxidative
stress and inflammation.
Fruits of the date palm (Phoenix dactylifera L.) are very
commonly consumed in many parts of the world and are
a vital component of the diet and a staple food in the Mid-
dle East and in North Africa. Nutritional value of date
palm fruit is attributed to its high contents of carbohy-
drates, salts, minerals, dietary fibers, vitamins, fatty acids,
amino acids, and protein [21]. The date palm fruit pos-
sesses many useful properties such as antioxidant and
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antimutagenic activity [22–29], antibacterial [30], antifun-
gal [31] and anti-tumoral [32]. Moreover, the aqueous and
ethanolic extracts of dates, were effective in ameliorating
the severity of gastric ulceration [33], nephrotoxicity [29]
and neurotoxicity [34] via antioxidant mechanisms. Al-
Qarawi et al. [35] and El-Gazzar et al. [25] demonstrated a
hepatoprotective effect of date palm fruit extract on oxida-
tive damage induced by CCl4. Moreover, aqueous extract
of date fruit has a protective effect against thioacetamide-
[24], trichloroacetic- [26] and dimethoate- [28] induced
oxidative damage in rat liver. Date palm fruits are com-
posed of a fleshy pericarp (flesh) and seeds (pits). The date
pits is also high in polyphenolics and antioxidants [36].
The protective role of date pits extract on oxidative liver
damage was also investigated [35, 37].
Our recent work [38] presented evidence that the anti-
fibrotic effects of the aqueous extract of date flesh (DFE)
and pits (DPE) are not exclusively via antioxidant mech-
anism but also through downregulation of inflammatory,
fibrotic and angiogenic markers. In the present work we
aimed to investigate whether the DFE or DPE could
exert their antifibrotic effects via ameliorating the oxida-
tive DNA damage and/or stimulating the fibrolytic
processes (promotion of ECM degradation) through up-
regulation of MMPs and downregulation of TIMPs. In
addition, our study aimed to explore whether the anti-
inflammatory effects exerted by DFE and DPE in fibrotic
liver are mediated through alleviation of NF- κB pathway
and/or upregulation of HO-1 activity.
Coffee is one of the most popular and highly con-
sumed beverages worldwide. Extensive studies demon-
strated the beneficial role of coffee and its components
in the protection from various liver diseases [39–42].
Moreover, experimental studies have suggested that the
intake of instant coffee, conventional coffee, or any of its
components can reduce hepatotoxin-induced liver fibro-
sis in rats and mice [43–48]. Coffee is a rich source of
polyphenols and diterpenes which contribute to the abil-
ity of coffee to suppress the genotoxicity [49–51] and
NF-κB pathway [52–54] and to enhance HO-1 activity
[55, 56] in different animal models. Therefore and based
on its potential and beneficial protective effects on liver,
coffee was selected as a reference hepatoprotective agent
in the current study.
Methods
Animals
This study was conducted on adult male albino Wistar
rats weighing 180–200 g provided by the Experimental
Animal Center of King Saud University, College of Phar-
macy, Riyadh, KSA and housed at 21–25 °C and a 12 h
light/dark cycle in a well-prepared animal house. The
animals had free access to pellet food and tap water. The
research was conducted in accordance with the National
Institutes of Health Guide for Care and Use of Labora-
tory Animals and approved by the Animal Care Com-
mittee of King Saud University.
Chemicals, kits and antibodies
CCl4, thiobarbituric acid (TBA), trichloroacetic acid
(TCA), Bilirubin Assay Kit, normal and low melting
agarose and ethidium bromide were purchased from
Sigma-Aldrich chemical Co. (St Louis, MO, USA). Date
fruits of Mabroom variety were obtained from Kingdom
Dates Factory in Riyadh, Kingdom of Saudi Arabia. Date
pits powder was purchased from a local company in
Riyadh, Kingdom of Saudi Arabia. Instant coffee (Nes-
cafe®,) was obtained from Nestlé (Cheongju, Korea).
Commercial kits used for liver enzymes were purchased
from Randox Laboratories Ltd. (CRUMLIN, CO. An-
trim, UK). ELISA kits for assay of MMP-9, TIMP-1 were
obtained from R&D Co. (Quantikine, R&D systems,
Minneapolis, MN, USA). ELISA kit for the assay of 8-
hydroxy deoxyguanosine (8-OH-dG) was purchased
from Abnova Co. (CA, USA). Primary antibodies for de-
tection of α- SMA, COX-2, NF-κB p65, collagen I and
TIMP-2 were obtained from Santa Cruz (Santa Cruz
Biotechnology, CA, USA). Primary antibodies for immu-
nostaining of HO-1, collagen III and MMP-9 were
purchased from Abcam (Cambridge, UK). Secondary
antibody was obtained from Sigma-Aldrich. All other re-
agents were of analytical quality.
Preparation of date flesh extract
The aqueous date extract was prepared according to the
method of Al-Qarawi et al. [35]. The date flesh was
manually separated from the pits (seeds). The flesh is
then soaked in cold distilled water in a ratio 1:3 (g/ml)
and kept for 48 h in a refrigerator (4 °C) with continuous
stirring. The extract was then filtered and the aqueous
supernatant was used.
Preparation of date pits extract
The dried pit powder was purchased from a local com-
pany in Riyadh. The powder was soaked with water in a
ratio 1: 10 (g/ml) under agitation and kept at 4 ° C for
48 h. After 48 h, the extract was filtered and the aqueous
supernatant was used [38]. Aqueous extract was selected
for both flesh and pits to get the advantages of all anti-
oxidant contents because most of the antioxidants and
active components in dates are extracted in water [23].
Preparation of CCl4 and induction of liver fibrosis
CCl4 was prepared by dissolving in corn oil (40 % v/v).
Liver fibrosis was induced by intraperitoneal injection of
0.4 ml/kg of CCl4 3× weekly for 8 weeks.
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Experimental design
Animals were randomly divided into five groups of ten
rats each as follows: Group I: Normal control with no
treatment; Group II: Model control rats injected with
CCl4 only (0.4 ml /kg; i.p.; 3× weekly for 8 weeks);
Groups III and IV: rats injected with CCl4 3 × weekly for
8 weeks and concomitantly treated with aqueous date
flesh extract (DFE; 6 ml/kg) or aqueous date pits extract
(DPE; 6 ml/kg); respectively by oral gavage daily for
8 weeks. Group V: is the positive control group com-
posed of rats injected with CCl4 3× weekly for 8 weeks
and concomitantly treated with coffee (300 mg/kg, dis-
solved in hot water). The dose of both DFE and DPE
(6 ml/kg) was selected based on a previous study per-
formed on our lab using 4 doses for each extract (2, 4, 6
and 8 ml/kg) in CCl4-treated rats [38]. The end points
were Masson trichome staining to detect collagen depos-
ition. The doses 6 and 8 ml/kg showed the best and
similar improvement in collagen deposition, so the dose
6 ml/kg was chosen to complete the study [38]. The
dose of coffee was chosen considering four standard
cups as the amount drinking daily.
Preparation of serum and tissue homogenate
At the end of 8 weeks, rats were anesthetized and sacri-
ficed by decapitation. Blood samples were collected, and
divided into two parts; one part was allowed to coagu-
late, centrifuged at 3000 rpm for 15 min to separate
serum. Sera were used for determination of liver en-
zymes activities and bilirubin levels. Second part was
collected in EDTA-tubes, and centrifuged to separate
plasma. Plasma samples were used to determine the
levels of advanced oxidation protein products (AOPPs).
The livers were removed and cleaned from excess blood
with ice-cold normal saline. A part of each liver was
fixed with 4 % formalin in phosphate buffered saline
(PBS; pH 7.4) for at least 24 h and prepared for immu-
nohistochemical detection of α-SMA, NF-κB p65, COX-
2, HO-1, collagen I, collagen III, MMP-9 and TIMP-2.
One gram of each liver was sampled and homogenized
(20 % w/v) in cold PBS (NaCl 8 g/L, KCl 0.2 g/L,
Na2HPO4 144 g/L and KH2PO4 0.24 g/L, pH 7.4) by
using Ultra-Turax (IKA-USA) homogenizer. The result-
ing tissue homogenates were centrifuged at 3000 rpm at
4 °C for ten minutes. The collected supernatant was di-
vided into aliquots and then kept at −80 °C till being
used for the assay lipid peroxides, catalase, 8 OH-dG,
MMP-9 and TIMP-1.
Evaluation of liver function
Serum activities of liver enzymes, alanine aminotransfer-
ase (ALT) and aspartate aminotransferase (AST), and
serum levels of total and direct (conjugated) bilirubin
were measured with routine laboratory methods using
commercially available kits according to manufacturer’s
instructions.
Assessment of oxidative stress markers
Determination of thiobarbituric acid reactive substances
(TBRS, a marker of lipid peroxidation
Lipid peroxidation was determined by estimating the
level of thiobarbituric acid reactive substances (TBARS)
measured as malondialdehyde (MDA), according to the
method of Ohkawa et al. [57]. MDA is an end product
in the sequence of lipid peroxidation reactions and so
was taken as an index for this process. Briefly, the reac-
tion mixture (0.5 ml homogenate + 2.5 ml 20 % TCA
+1.0 ml 0.6 % TBA) was heated for 30 min in a boiling
water bath. The mixture was then cooled and centri-
fuged for 10 min at 4 °C. The absorbance of the devel-
oped pink-colored product was measured at 535 nm
against a reagent blank. 1, 1, 3, 3-tetraethoxypropane, a
form of MDA, was used as standard in this assay. The
results were expressed as nmol of MDA/g of wet tissue.
Assay of advanced oxidation protein products (AOPPs), a
marker of protein oxidation
The determination of plasma AOPPs was based on spec-
trophotometric detection according to Witko-Sarsat et
al. [58]. Briefly, 200 μl of plasma (diluted 1:5 with PBS as
a test), 200 μl of chloramine-T solution (0–100 μmol/L)
for calibration and 200 μl of PBS as a blank were ap-
plied. A 10 μl of 1.16 M potassium iodide and 20 μl of
acetic acid were added, and the absorbance at 340 nm
was measured immediately. The concentration of
AOPPs was expressed as μmol/l of chloramine-T
equivalents.
Assay of catalase (CAT) as enzymatic antioxidant
CAT activity was estimated as the decomposition rate of
hydrogen peroxide according to the method of Aebi
[59]. In brief, 50 μl of liver homogenate was diluted with
5 ml of phosphate buffer, and then 2 ml of the diluted
homogenate was mixed with 1 ml hydrogen peroxide.
The absorbance was read after 15 and 30 s at 240 nm.
Markers of DNA damage
Assay of 8-OHdG
The hepatic levels of 8-OHdG (an abundant form of oxi-
dative DNA damage) were determined by enzyme-linked
immunosorbent assay (ELISA) using rat immunoassay
kits (Abnova Co). According to the manufacturer’s in-
structions, two freeze-thaw cycles of liver homogenate
samples were performed to break cell membranes, then
the homogenates were centrifugated at 5000xg for 5 min
and the assay was performed on the supernatant as indi-
cated by the instructions.
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Comet DNA assay (marker for DNA fragmentation)
The standard procedure was originally described by
Singh et al. [60] and modified by Hu et al. [61]. A small
piece of liver samples was minced, suspended in 4 ml
chilled homogenizing solution (pH 7.5) containing
0.075 M NaCl and 0.024 M Na2EDTA and then homog-
enized gently at 500 to 800 rpm in ice. 100 μl of liver
homogenate was mixed with 600 μl of low-melting agar-
ose (0.8 % in PBS). 100 μl of this mixture was spread on
slides pre-coated with 300 μl of 0.6 % normal melting
point agarose (NMP). After application of a third layer
of 0.6 % NMP (300 μl), slides were immersed in ice-cold
lysis buffer (0.045 M Trisborate- EDTA (TBE) buffer,
pH 8.4) for 1 h at 4 °C. Slides were then removed from
the lysing solution and placed for 20 min in a horizontal
electrophoresis unit filled with an alkaline buffer (1 mM
Na2EDTA and 300 mM NaOH, pH 13) to allow the un-
winding of DNA. After the unwinding of DNA, electro-
phoresis was carried out under standard conditions
(25 V, 300 mA, and distance between electrodes 30 cm)
for 20 min at room temperature in the same alkaline so-
lution (pH 13). Electrophoresis at high pH results in
structures resembling comets, as observed by fluores-
cence microscopy; the intensity of the comet tail relative
to the head reflects the number of DNA breaks. The
slides were then neutralized by adding 0.4 M Tris-HCl
buffer (pH 7.5), stained with ethidium bromide (20 μg/
ml) at 4 °C, covered and stored in sealed boxes at 4 °C
until image analysis. All preparation steps were per-
formed under dimmed light to prevent additional DNA
damage by UV. Images of 100 randomly selected cells
were analyzed for each sample. DNA fragment migration
patterns was evaluated with Leitz Orthoplan epifluores-
cence microscope (magnification 250×) equipped with
an excitation filter of 515–560 nm and a barrier filter of
590 nm. The microscope was connected through a cam-
era to a computer-based image analysis system (Comet
Assay IV software, Perspective Instruments). Comets
were randomly captured at a constant depth of the gel,
avoiding the edges of the gel, occasional dead cells, and
superimposed comets. DNA damage was measured as
tail length (TL = distance of DNA migration from the
centre of the body of the nuclear core), tail intensity (TI
= % of DNA that migrated from the nuclear core to the
tail) and tail moment. The tail moment (TMOM) was
determined according to the formula: TMOM=DNA in
tail as a % of total DNA x tail length (TL).
ELISA assay of MMP-9 and TIMP-1
The hepatic levels of MMP-9 (a collagen degrading en-
zyme) and TIMP-1 (a tissue inhibitor of collagen degrad-
ation) were determined by enzyme-linked immunosorbent
assay using rat immunoassay kits (R&D Systems) accord-
ing to the manufacturer’s instructions.
Immunohistochemistry for detection of collagen I, collagen
III, α-SMA, COX-2, NF-κB p65, HO-1, MMP-9 and TIMP-2
The following primary antibodies were used for immuno-
staining of paraffin sections of the liver: goat polyclonal
anti-collagen I antibody (sc-25,974), mouse monoclonal
anti-collagen III antibody (ab 82,354), mouse monoclonal
anti-α-SMA (sc-130,617), goat polyclonal anti-COX-2 (sc-
1747), mouse monoclonal anti-NF-κB p65 (sc-8008),
rabbit polyclonal anti-HO-1 (ab85309), rabbit monoclonal
anti-MMP-9 (ab76003) and goat polyclonal anti-TIMP-2
(sc-6835). Immunostaining was performed using Immuno
Cruz ABC staining system from Santa Cruz. The proced-
ure involved the following steps: endogenous peroxidase
activity was inhibited by 3 % H2O2 in distilled water for
5 min, and then the sections were washed in Tris buffered
saline (Sigma, T 5030–100 TAB, pH 7.6) for 10 min. Non-
specific binding of antibodies was blocked by incubation
with protein block for 5 min. Sections were incubated with
the primary antibodies (diluted 1:100, except for anti- α–
SMA which is diluted 1:200) for 1 h at room temperature.
Sections were washed in Tris buffer for 3 times each for
3 min, and then incubated with biotinylatedantirabbit IgG
for 30 min. This was followed by washing in Tris buffer for
3 times, each for 3 min. Peroxidase was detected with
working solution of Diaminobenzedine substrate for
10 min. Finally sections were washed in distilled water for
10 min, nuclei were stained with Mayer’s hematoxylin and
sections were mounted in DPX. For negative control sec-
tions, the same procedure was followed with omission of
incubation in the primary antibody.
Statistical analysis
The results are expressed as the mean ± SEM. Statistical
comparisons between the groups were performed using
one-way analysis of variance (ANOVA) followed by a
Tukey-Kramer post hoc test. Statistical analysis was con-
ducted using Prism GraphPad software version 4 (San
Diego, California, USA). P values < 0.05 were considered
statistically significant.
Results
Effect of DFE and DPE on liver functions in CCl4-intoxicated
rats
Estimation of liver function revealed that CCl4 induced a
significant increase in serum ALT and AST activities and
in total and direct bilirubin levels compared to the nor-
mal control group (P <0.001). Serum levels of ALT, AST
and both direct and total bilirubin were significantly re-
duced by the concurrent treatment with DFE, DPE and
coffee compared to CCl4-intoxicated group (Fig. 1).
DFE-treated rats showed significant lower levels of total
and direct bilirubin compared to both DPE- and coffee-
treated groups (P <0.05), and decreased ALT activity
compared to coffee-treated rats (P <0.05).
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Effect of DFE and DPE on oxidative stress markers in
CCl4-intoxicated rats
CCl4-induced oxidative stress in rat livers was evaluated by
assessing lipid peroxides, AOPP and CAT (as an antioxi-
dant enzyme) in hepatic tissues (Table 1). CCl4 significantly
increased the levels of TBARS and AOPP compared to
normal control group (P <0.001) reflecting both lipid and
protein oxidation, respectively. Furthermore, CCl4 signifi-
cantly reduced the hepatic activities of CAT compared to
normal control group (P <0.001). Treatment with DFE,
DPE or coffee concomitantly with CCl4 presented signifi-
cant protection against CCl4-induced oxidative stress as in-
dicated by the significant decrease in TBARS and AOPP
levels (P <0.001) together with significant rise in the activ-
ities of CAT (P <0.001, P <0.01) compared to CCl4-intoxi-
cated rats. DFE-treated rats showed significant improved
levels of AOPP and CAT compared to both DPE- and
coffee-treated groups (P <0.05), and lowered TBARS levels
compared to coffee-treated rats (P <0.05).
Effect of DFE and DPE on markers of oxidative DNA
damage in CCl4-intoxicated rats
Figures 2 and 3 & Table 2 demonstrated a DNA damage
induced by CCl4 as assessed by measurement of 8-
OHdG and comet assay. CCl4 resulted in marked
elevation of 8-OHdG compared to normal control (P
<0.001), however the concomitant treatment with DFE,
DPE and coffee significantly subsided these levels com-
pared to CCl4-intoxicated rats (P <0.001, Fig. 3). No sig-
nificant difference was observed in DFE- or DPE-
treated rats compared to coffee-treated group. Comet
DNA assay (Fig. 2 and Table 2) indicated DNA damage
in CCl4-intoxicated rats as revealed by significant in-
crease in tailed DNA%, tail length, tail intensity and tail
moment compared to normal control (P <0.001), while
simultaneous treatment with DFE, DPE or coffee signifi-
cantly diminished this damage (Table 2). Treatment with
DFE significantly reduced the tail length (P <0. 05) and
tail moment (P <0.001) compared to DPE, while no sig-
nificant difference in any of DNA damage indices was
observed compared to coffee-treated group
Effect of DFE and DPE on expression of collagen I and
collagen III
Immunostaining of collagen type I, the most com-
mon type of collagens in tissues, was performed to
assess the degree of fibrosis in hepatic tissue (Fig. 4a).
Liver sections from normal control group (Panel A)
displayed normal faint immune positive areas that re-
stricted to the portal areas. In contrast, liver sections
Fig. 1 Effect of DFE, DPE and coffee on liver function markers in CCl4-intoxicated rats. a significantly different from normal control group;
b significantly different from CCl4-treated group; c significantly different from DFE-treated rats. Values are expressed as mean ± SEM. *** P < 0.001,
** P < 0.01, * P < 0.05. ALT: alanine aminotransferase; AST: aspartate aminotransferase
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from CCl4-inotxicated group showed dense abnormal
immune positivity of scattered patches near to the
degenerated areas (Panel B). Interestingly, treatment
with DFE, DPE or coffee along with CCl4 showed
marked decrease of the amount and density of
abnormal fibrosis (Panels C to E, respectively). The
improvement was notably prominent in rats treated
with DFE. Immunohistochemical detection of colla-
gen type III (Fig. 4b) supported these results where
liver section of rat received CCl4 showed strong wide
abnormal irregularly distributed immune reactivity
(Panel B), whereas liver section from rats treated
with DFE, DPE or coffee, revealed marked decrease
of the intensity of the immune reactivity of hepato-
cytes surrounding portal areas especially in rats
received DFE.
Effect of DFE and DPE on expression of α-SMA in
CCl4-intoxicated rats
Hepatic expression of α-SMA was detected as the key
marker of HSCs activation (Fig. 5). HSCs are the major
cellular source of collagen and their activation plays a
key role on fibrogenesis. Liver section from control
group (Panel A) revealed minimal staining of α-SMA in
the blood vessels which restricted around the portal area
without positive immunostaining between hepatocytes.
In contrast, marked expression of α-SMA was observed
in the CCl4-intoxicated rats particularly around degener-
ated hepatocytes, as shown by the intense brown stain-
ing (Panel B). Co-administration of DFE, DPE or coffee
markedly attenuated this elevated expression (Panels C
to E, respectively) where the immune reactivity is re-
stricted to the vessels of the portal areas. The improve-
ment was prominent with DFE.
Effect of DFE or DPE on hepatic levels and expression of
fibrolytic markers (MMP-9, TIMP-1 and TIMP-2) in
CCl4-intoxicated rats
Figure 6b showed that hepatic levels of MMP-9 were
significantly elevated in CCl4-intoxicated rats compared
to normal control group (P < 0.01). Concomitant treat-
ment with DFE, DPE and coffee didn’t modify the
MMP-9 levels compared to CCl4-intoxicated rats. These
results were confirmed by the Immunohistochemical de-
tection of MMP-9 in liver tissue (Fig. 6a) where rats re-
ceived CCl4 exhibited strong abnormal immune
reactivity of most of hepatocytes’ cytoplasm and nuclei
(Panel B). Also, rats concomitantly received DFE, DPE
or coffee revealed many hepatocytes with strong positive
immune reactivity for MMP-9 (Panels C to E). Concern-
ing TIMP-1 and -2, our results showed a marked in-
crease in the hepatic levels of TIMP-1 in CCl4-treated
Table 1 Effects of DFE, DPE and coffee on hepatic oxidative
stress markers; TBARS (a marker of lipid peroxidation), AOPP (a
marker of protein oxidation) and CAT (as enzymatic antioxidant)







Control 72.4 ± 7.28 69.43 ± 0.44 6.74 ± 0.15
CCl4 158.7
a*** ± 12.1 208.2 a*** ± 10.7 4.23 a*** ± 0.38
DFE+ CCl4 93.17
b*** ± 5.62 114.1 b*** ± 6.13 5.9 b*** ± 0.147
DPE+ CCl4 107.8
b*** ± 6.54 154.3b*** c* ± 10.32 5.2 b**c* ± 0.2
Coffee + CCl4 129.3
b***c* ± 7.9 155.1 b*** c* ± 10.23 5.04 b**c* ± 0.26
***P < 0.001, **P < 0.01, *P < 0.05
asignificantly different from normal control group; bsignificantly different from
CCl4-treated group,
csignificantly different from DFE-treated rats
Fig. 2 Effect of DFE, DPE and coffee on comet DNA assay in liver
tissues in CCl4-intoxicated rats
Fig. 3 Effect of DFE, DPE and coffee on hepatic levels of 8-OHdG as
a marker of DNA damage. Values are expressed as mean ± SEM. a
significantly different from normal control group; b significantly
different from CCl4-treated group. *** P < 0.001
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rats compared to normal control (P < 0.001) (Fig. 7b). In
addition, positive immune reactivity of TIMP-2 was ob-
served in liver sections from CCl4-intoxicated rats
(Fig. 7a, Panel B). The hepatic levels of TIMP-1 and im-
munoreactivity of TIMP-2 were significantly mitigated
by treatment with DFE, DPE and coffee compared to
CCl4-intoxicated rats (P < 0.001). The hepatic levels of
TIMP-1 were significantly alleviated in DFE-treated rats
compared to coffee-treated group (P < 0.05), while no
significant differences were observed in DPE compared
to either DFE- or coffee-treated group. The TIMP-2 ex-
pression detected by immunostaining revealed lower im-
mune reactivity in both DFE- and DPE-treated groups
(Fig. 7a, Panels C and D) compared to coffee (Panel E).
Effect of DFE or DPE on inflammatory makers in
CCl4-intoxicated rats
The effect on the expression of COX-2
The expression of the proinflammatory enzyme, COX-2
was estimated using immunohistochemical staining
(Fig. 8). Liver section from normal control group showed
minimal immunostaining for COX-2 (Panel A); while
the section from CCl4−intoxicated rat revealed enhanced
expression of this enzyme as shown by the intense
brown staining (Panel B). Rats received CCl4 showed ab-
normal irregularly distributed immune reactivity of
COX-2, especially between degenerated hepatocytes’
cytoplasm and nuclei and many nuclei are also positively
stained. Concomitant treatment with DFE, DPE and cof-
fee attenuated this elevation to a large extent (Panels C
to E, respectively), where liver sections showed marked
decrease of the intensity of the hepatocytes’ immune re-
action surrounding portal areas especially in rats treated
with DFE.
The effect on the expression of NF-κB (p65)
NF-κB was assessed by detecting the activated subunit
p65 in liver tissues (Fig. 9). Control rats showed minimal
nuclear immunostaining for NF-κB p65 with normal
cytoplasmic distribution (Panel A). CCl4 induced an in-
crease in the p65 expression and activation in the liver
tissues, which was evident from the intense staining of
cytoplasm and focal strong abnormal immune reactivity
of most of hepatocytes’ nuclei (Panel B). However, co-
treatment with DFE, DPE and coffee significantly de-
creased the expression of NF-κB p65 (Panels C to E,
respectively). Liver sections from rats received DFE, DPE
or coffee revealed decreased number of immunostained
nuclei of hepatocytes reflecting reduced nuclear trans-
location and suppression of activation particularly in rats
treated with DFE and coffee.
The effect on the expression of HO-1
The expression of HO-1, an antioxidant and anti-
inflammatory enzyme, was shown in Fig. 10. Normal
control rat showed strong immune reaction of most of
hepatocytes’ cytoplasm (Panel A), while CCl4-intoxicated
rat’s liver revealed few hepatocytes with weak immune
reaction (Panel B). Concurrent treatment with DFE
(Panel C) and coffee (Panel E) showed patches of hepa-
tocytes with moderate immune reaction, while, treat-
ment with DPE showed less prominent improvement
where mild weak immune positivity of few hepatocytes
were observed (Panel D).
Discussion
Carbon tetrachloride (CCl4) intoxication is a frequently
used model of liver injury. CCl4 is activated by hepatic
microsomal cytochromes to form the trichloromethyl
(CCl3•) and trichloromethylperoxyl (OOCCl3•) radicals
which are highly unstable and immediately activate oxi-
dation of polyunsaturated fatty acids of hepatocellular
membrane leading to its damage and increased perme-
ability [62]. Another possibility is the covalent binding of
CCl3• to the hepatic microsomal lipids and proteins that
damage the integrity of the structure and function of
hepatic cell membranes [62] leading to leakage of liver
enzymes into circulation and their elevation in serum
(Fig. 1). Liver damage was also confirmed in the present
study by the elevated levels of total and conjugated bili-
rubin that reflect the liver’s inability to take up, process,
and secrete bilirubin into the bile. Recently, we reported
the hepatoprotective effects of both DFE and DPE in
CCl4-induced fibrosis in rats [38] via reducing oxidative










Control 4.25 ± 0.31 1.67 ± 0.045 2.56 ± 0.046 4.75 ± 0.161
CCl4 9.25
a*** ± 0.44 3.25 a*** ± 0.1 3.7 a*** ± 0.068 11.74 a*** ± 0.324
DFE+ CCl4 6.83
b** ± 0.31 2.48 b*** ± 0.11 2.87 b*** ± 0.038 7.84 b*** ± 0.24
DPE+ CCl4 6.84
b** ± 0.477 2.83 b*c* ± 0.08 2.83 b*** ± 0.057 9.12 b**c** ± 0.084
Coffee + CCl4 7.25
b** ± 0.362 2.64 b** ± 0.176 2.73 b*** ± 0.042 8.43 b*** ± 0.22
***P < 0.001, **P < 0.01, *P < 0.05
asignificantly different from normal control group; bsignificantly different from CCl4-treated group;
csignificantly different from DFE-treated group
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Fig. 4 (See legend on next page.)
Attia et al. BMC Complementary and Alternative Medicine  (2016) 16:414 Page 9 of 18
stress, inactivation of HSCs, and reducing levels of in-
flammatory and angiogenic markers. In this study we fo-
cused on the following mechanisms: i-suppression of
genotoxicity, ii- the fibrolytic potential of both extracts
via modulating the expression of MMPs and TIMPs, and
iii-downregulation of NF-κB pathway and/or upregula-
tion of HO-1.
Cellular lipids are easily attacked by free radicals pro-
duced from the metabolism of CCl4 that initiates a chain
reaction to cause lipid peroxidation and cell membrane
damage [62]. Protein is also susceptible to damage by CCl4-
induced free radicals. AOPPs are dityrosine-containing
cross-linked protein products formed during oxidative
stress and are considered to be reliable markers for estimat-
ing the degree of oxidant-mediated protein damage [63]. In
our study, CCl4 resulted in increased hepatic levels of MDA
and plasma levels of AOPPs indicating lipid peroxidation
and the oxidative protein damage, respectively. In addition,
hepatic CAT activity was reduced reflecting the consump-
tion of this antioxidant enzyme. Moreover, we previously
demonstrated that CCl4 caused depletion of GSH, SOD
and GPx confirming the oxidative stress in liver tissue [38].
Our previous and present work reported that both DFE
and DPE exhibited potent protective effects against CCl4-
(See figure on previous page.)
Fig. 4 Effect of DFE, DPE and coffee on collagen deposition in CCl4-intoxicated rats. (a): Light microscopic photomicrographs of liver tissue
immunostained with anti-collagen type I primary antibody (Scale bar = 100 μm). Panel a represents liver section from control group showing normal faint
immunopositive areas that restricted to the portal areas (arrow). Panel b represents liver section of rat received CCl4 showing dense abnormal immune
positivity of scattered patches near to the degenerated areas (arrows). Liver sections from rats treated with DFE (Panel c), DPE (Panel d) and coffee (Panel
e) showing marked decrease of amount and density of abnormal fibrosis (arrows). The improvement is prominent in DFE-treated group. (b): Light
microscopic photomicrographs of liver tissue immunostained with anti-collagen III primary antibody (Scale bar = 50 μm). Panel a represents liver section
from control group showing normal immunopositive collagen distribution mainly in portal area (arrow), while Panel b represents liver section of rat
received CCl4 in which strong wide abnormal irregularly distributed immune reactivity (arrow) was detected. Panels c d and e represent liver sections
from rats treated with DFE DPE and coffee, respectively showing marked decrease of the intensity of the immune reactivity of hepatocytes surrounding
portal areas especially in rats received DFE (arrows)
Fig. 5 Light microscopic photomicrographs of liver tissue immunostained with primary anti α-SMA antibody (Scale bar = 50 μm). Panel a represents
liver section from control rat showing normal positive immune reactivity of smooth muscle of the blood vessels of the portal area without immune
staining positivity in between hepatocytes, while Panel b represents liver section of rat received CCl4 in which strong abnormal distributed immune
reactivity, especially around degenerated hepatocytes, is prominent. Panels c d and e represent liver sections from rats received DFE, DPE and coffee,
respectively, showing marked decrease of the immune reactivity outside portal areas especially in the group received DFE
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mediated oxidative damage via decreasing hepatic levels of
MDA and increasing the levels and activities of GSH, CAT,
SOD and GPx. In addition, the present work also demon-
strated that DFE and DPE alleviated protein oxidation as
evidenced by reduced plasma levels of AOPPs.
Like other macromolecules such as lipids and proteins,
nucleic acids are also attacked by free radicals to cause
oxidative DNA damage. DNA strand breaks and forma-
tion of 8-OHdG are abundant forms of oxidative damage
induced by highly reactive free radicals [13, 14]. Even
when the levels of these radicals are too low to cause
such lethal damage, chronic exposure to cells can lead to
accumulation of 8-OHdG in DNA. 8-OHdG is generated
by oxidation of C8 of guanine and forms pairs with un-
desirable adenine residue in addition to authentic cyto-
sine residue in DNA, thereby leading to a greatly
increased frequency of G:C to T:A transversion mutation
and DNA damage [64]. Moreover, and according to
Marnett [65], the product of lipid peroxidation react
with DNA to form adducts MIG, the mutagenic adduct
of deoxyguanosine. Alkreathy et al. [66] demonstrated
that CCl4 degrades the DNA of liver tissue of rats by
generating free radicals. In the present study, chronic
Fig. 6 Effect of DFE and DPE on fibrolytic markers in CCl4-
intoxicated rats. (a): Light microscopic photomicrographs of liver
tissue immunostained with MMP-9 primary antibody (Scale bar =
50 μm). Panel a represents liver section from control group showing
normal few immune positive cells’ cytoplasm (arrow) while the
nuclei are not immunostained. Panel b represents liver section of rat
intoxicated with CCl4 in which strong abnormal immune reactivity
of most of hepatocytes cytoplasm and nuclei. Panels c d and e
represent liver sections from rats treated with DFE, DPE and coffee,
respectively revealed, many hepatocytes with strong positive immune
reactivity in both cell’ cytoplasm and nuclei especially with coffee-treated
group (arrows). (b): Effect of DFE, DPE and coffee on hepatic levels of
MMP-9 in CCl4-intoxicated rats. Values are expressed as mean ± SEM. a:
significantly different from normal control group. ** P < 0.01
Fig. 7 Effects of DFE and DPE on fibrolytic markers in CCl4-intoxicated
rats. (a): Light microscopic photomicrographs of liver tissue
immunostained with anti TIMP-2 primary antibody (Scale bar = 100 μm).
Panel a represents liver section from control rat showing normal absence
of immune positivity. Panel b represents liver section of rat intoxicated
with CCl4 in which there are focal strong wide areas of abnormal
immune reactivity of most of hepatic tissue. Panels c d and e represents
liver sections from rats treated with DFE, DPE and coffee, respectively,
revealed a decrease of immunostained areas which appeared weak in
reaction. (b): Effect of DFE, DPE and coffee on hepatic levels of TIMP-1 in
CCl4-intoxicated rats. Values are expressed as mean ± SEM. a: significantly
different from normal control group; b: significantly different from CCl4-
treated group; c: significantly different from DFE-treated rats.
*** P < 0.001, * P < 0.05
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exposure to CCl4 lead to a significant rise in the hepatic
levels of 8-OHdG in addition to DNA fragmentation in-
dicated by significant increase in tailed DNA %, tail
length, tail intensity and tail moments which is probably
associated with increased production of reactive oxygen
species. Various forms of oxidative damage induced by
CCl4 in liver may be prevented by antioxidants supple-
mentation which represents a rationale for using them
in the treatment of liver disorders. In this regard, the
protective effects of DFE and DPE against CCl4-induced
genotoxicity were evaluated in the current work. We
found that hepatic levels of 8-OHdG and all indices of
DNA fragmentation (tailed DNA %, tail length, tail in-
tensity and tail moments) were significantly lower in
DFE- and DPE- treated rats supporting the protective ef-
fects of both extracts against genotoxicity. These pro-
tective effects could be attributed to the antioxidant
potential of DFE and DPE that is believed to be due to
the wide range of polyphenolic compounds (p-coumaric,
ferulic, sinapic acids, flavonoids, anthocyanins, phenolic
acids and procyanidins), and trace elements (selenium,
copper, zinc and manganese), in addition to vitamin C
present in the date palm fruit flesh [23, 27] and pits [37].
The antioxidant potential of DFE and DPE may be also
related to their ability, particularly DFE, to preserve the
expression of the antioxidant enzyme, HO-1, in liver
cells (Fig. 10). Our work is the first in vivo study investi-
gating the protective role of dates fruit extract against
oxidative DNA damage. Similar to our results, the in
vitro study performed by Vayalil [22] proved the antioxi-
dant and antimutagenic activity of the aqueous date
palm fruit extract resulting from the inhibition of both
lipid and protein oxidation and also by the aptitude of
this extract to scavenge superoxide and hydroxyl radi-
cals. Our results concerning coffee, as a reference antifi-
brotic agent, supported the previous studies reporting
that coffee intake is associated with lower levels of
oxidative DNA damage and reduced levels of 8-OHdG
[49–51]. Various components of coffee that have been
related to such a favorable effect include caffeine, coffee
oils kahweol, cafestol and antioxidant substances.
Fibrogenesis is mainly characterized by the activation of
HSCs with increased production of ECM particularly col-
lagens and the secretion of α-SMA; the hall mark for HSC
activation [1]. Our results revealed significantly higher ex-
pression of collagen I, collagen III and α-SMA in the liver
Fig. 8 Light microscopic photomicrographs of liver tissue immunostained with primary anti COX-2 antibody (Scale bar = 50 μm). Panel a represents
liver section from control rat showing very faint or weak immune-reactivity of hepatocytes, while panel b represents liver section of rat received CCl4
in which strong abnormal irregularly distributed immune reactivity was observed, especially between degenerated hepatocytes’ cytoplasm and nuclei
(arrow). Many nuclei are also positively stained (arrow). Panels c d and e represent liver sections from rats treated with DFE, DPE and coffee, respectively
showing marked decrease of the intensity of the immune reactivity of hepatocytes surrounding portal areas especially in rats treated with DFE (arrows)
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of CCl4-intoxicated rats indicating fibrogenesis. On the
other hand, treatment with DFE and DPE successfully al-
leviated the fibrotic changes in rat’s liver as indicated by
the reduced expression of α-SMA, collagen I and collagen
III which confirm our previous results reporting the ability
of DFE and DPE to reduce collagen deposition, hydroxy-
proline and TGF-β1, the most potent fibrotic factor, in
hepatic cells [38]. Among several types of cells and cyto-
kines involved in HSCs activation, the transcription factor
NF-κB plays a crucial role [67]. DNA binding activity of
NF-κB is demonstrated in activated but not in quiescent
HSCs and activation of HSCs is associated with the nu-
clear translocation of NF-κB. The current results suggest
that the strong immunostaining of NF-κB p65 (Fig. 9,
panel B) may play a pivotal role in HSCs activation. More-
over, the current study suggest that the ability of both
DFE and DPE to inhibit HSCs activation and collagen ac-
cumulation is partly due to blocking NF-κB activation in-
dicated in the present study by decreased NF-κB p65
immunoreactivity (Fig. 9, panels C and D). We previously
presented additional mechanism of the inhibitory effect of
DFE and DPE on HSCs activation via reducing the levels
of TGF-β1, TNF-α, IL-6 and IL-1β, the most important
cytokines involved in HSCs activation [38].
To further investigate the antifibrotic mechanisms of
DFE and DPE in hepatic cells, their ability to induce col-
lagen degradation was elucidated in the current study.
In healthy liver, MMPs and TIMPs play an important
role in inducing and preventing the degradation of the
ECM, respectively. The imbalance between MMPs and
TIMPs is considered a pivotal mechanism of ECM de-
position and liver fibrogenesis [5]. Among different
MMPs and TIMPs, MMP-9 is known as the regulator
for the breakdown of ECM, while TIMP-1 and -2 exhibit
anti-fibrolytic and growth-stimulated activities [68]. In
this study, CCl4-intoxicated rats revealed significantly
higher levels and expression of MMP-9 which is consist-
ent with the previous studies conducted on chronic
models of CCl4-induced liver fibrosis [69–71]. Moreover,
MMP-9 is produced in CCl4-induced liver injury after a
single injection [72] and in hepatitis C virus-induced cir-
rhosis [73]; however, its activity was not related to the
degree of fibrosis [74]. In this regard, the levels and ex-
pression of MMP-9 in our study were increased in CCl4-
intoxicated rats’ liver, possibly due to HSC activation [3].
It has been demonstrated that the antifibrotic efficacy is
associated with a decreased hepatic level of MMP-9 [70].
However, in our study, no significant change in the
Fig. 9 Light microscopic photomicrographs of liver tissue immunostained with anti NF-κB p65 primary antibody (Scale bar = 50 μm). Panel a
represents liver section from control rat showing normal cytoplasmic distribution (curved arrow) with negative immune reactivity in most of nuclei
(arrowheads). Only few weak immune positive nuclei (arrows) were observed. Panel b represents liver section of rat intoxicated with CCl4 in which
there are focal strong abnormal immune reactivity of most of hepatocytes nuclei (arrows) and deeply stained cytoplasm (curved arrows). Panels c
d and e represent liver sections from rat treated with DFE, DPE and coffee, respectively, revealing decreased number of immunostained nuclei of
hepatocytes (arrows) where most of nuclei were negatively stained (arrowheads) particularly in DFE-and coffee-treated groups
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levels and expression of MMP-9 was observed by treat-
ment with DFE, DPE or coffee compared to CCl4-intoxi-
cated rats suggesting the antifibrotic effect may not be
related to modulation of MMP-9 activity.
TIMP-1 and TIMP-2 are capable of inhibiting the activ-
ities of all known MMPs and, in consistent with our re-
sults, their expressions are increased in CCl4-induced liver
fibrosis [69, 70, 74]. Activation of HSCs in culture and in
vivo is accompanied by increased expression and secretion
of TIMP-1 and TIMP-2 [74, 75]. Therefore in the pres-
ence of a hepatotoxic agent, HSCs are activated, and the
TIMP-1 and -2 are upregulated, leading to fibrogenesis.
On the other hand, fibrosis resolution has been correlated
with a diminution of TIMP-1 and TIMP-2 [75, 76], there-
fore, TIMP-1 and TIMP-2 represent important thera-
peutic target of the antifibrotic strategies for chronic liver
disease [69, 76]. Our results revealed significant reduction
in the hepatic levels of TIMP-1 and expression of TIMP-2
in rats treated with DFE or DPE which imply a new and
significant antifibrotic mechanism for DFE or DPE via
fibrolytic activity. This significant downregulation in the
hepatic level of TIMP-1 and TIMP-2 by DFE and DPE
might be due to the following: First, the inhibition of
HSCs activity, as indicated by lowered expression of α-
SMA (Fig. 5, panel C and D); second, the diminished hep-
atic levels of TGF-β1 by DFE and DPE [38]. This inhibi-
tory effect on TGF-β1 is important because TGF-β1 plays
a key role in modulating the levels of ECM via inhibiting
MMPs, while simultaneously up-regulates expression of
TIMPs [77] leading to failure of ECM degradation and ac-
cumulation of collagen in hepatic tissue. The third explan-
ation of the fibrolytic activity of DFE and DPE is their
inhibitory effect on the secretion of inflammatory cyto-
kines, TNF-α, IL-6 and IL-1β [38] which are known to up-
regulate the TIMP-1 levels in rat and human hepatocytes
[78]. Our suggestion is supported by the study of
Roderfeld et al. [72] who demonstrated that cytokine
blockade inhibits the expression of TIMP-1 and up-
regulates the expression of MMP-9. In the current study,
immunohistochemical examinations showed that livers
from DFE- and DPE-treated rats exhibited significant re-
duction in collagens type I and type III reactivity (Fig. 4)
suggesting the beneficial role of DFE and DPE in the re-
moval of deposited collagen. This enhanced collagenolytic
activity could be strongly associated to the decreased
TIMP-1 and TIMP-2 levels by both extracts. In conclu-
sion, enhancement of matrix degradation might be in-
volved in the antifibrotic effects of DFE and DPE.
Fig. 10 Light microscopic photomicrographs of liver tissue immunostained with anti-HO-1 antibody (Scale bar = 50 μm). Panel a represents liver
section from control rat showing normal strong immune reaction of most of hepatocytes’ cytoplasm (arrows), while panel b represents liver
section of rat received CCl4 with few hepatocytes showing weak immune reaction (arrow). Liver sections from rats treated with DFE (Panel c) and
coffee (Panel e) showing patches of hepatocytes with moderate immune reaction (arrows). Panel D represents liver sections from rats treated with
DPE showing mild weak immune positivity of few hepatocytes (arrows)
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The proinflammatory mediators, TNF-α, IL-6 and IL-
1β can promote fibrosis via different mechanisms. Re-
cently, we reported the anti-inflammatory effects of DFE
and DPE in CCl4-iduced liver fibrosis via reducing the
aforementioned mediators [38]. However, the data con-
cerning anti-inflammatory effect of dates in liver toxicity
is still poor and inadequate. In the current study, we
aimed to investigate whether the anti-inflammatory ef-
fects of DFE and DPE are mediated through the modula-
tion of NF-κB and/or HO-1 pathways.
NF-κB provides an important mechanism of the inflam-
matory response in liver fibrosis. Activation of NF-κB
leads to production of the proinflammatory cytokines,
followed by activation of other inflammatory mediators,
such as COX-2 and iNOS [9]. In the current study, CCl4-
injured liver demonstrated strong immunostaining of NF-
κB p65 subunit that is located in nucleus. Cytoplasmic
NF-κB activation and its subsequent nuclear translocation
in CCl4-injured livers are suggested to be induced by
CCl4-generated free radicals [79]. NF-κB was also acti-
vated during transdifferentiation of HSCs into myofibro-
blasts like cells [1]. Importantly, the accumulation and
nuclear translocation of the NF-κB p65 subunit in the liver
cells of CCl4-intoxicated rats was significantly attenuated
by treatment with DFE or DPE suggesting their anti-
inflammatory activity through suppression of NF-κB acti-
vation. The inhibitory effects of DFE and DPE on NF-κB
p65 may be attributed to their role in HSCs inactivation
or may be related to their polyphenols, flavonoids and an-
thocyanins contents which are documented to suppress
COX-2 expression and inhibit NF-κB translocation in pre-
vious studies [80]. Moreover, the inhibitory effect of DFE
and DPE on NF-κB could be further explained by their
ability, particularly DFE, to preserve HO-1 enzymatic ac-
tivity as demonstrated in the current study in Fig. 10
(panels C and D). Yang et al. [81] demonstrated a potential
mechanism that HO-1 prevents the expression of NF-κB
in fibrotic liver tissue. In addition, Xue et al. [18] suggest
that high levels of HO-1 expression may decrease NF-κB
expression to lessen the inflammatory reaction at 6 h after
reperfusion in cirrhotic rats. Concerning coffee, our re-
sults supports previous data reported the inhibitory effect
of coffee on NF-κB in vitro and in vivo [52–54]. The
coffee-induced NF-κB inhibition activity was attributed
mainly to polyphenolics and melanoidins, two major cof-
fee chemical groups [53, 54]. The upregulation of HO-1
enzyme activity as demonstrated in the current study
(Fig. 10, panel E) may further explain the role of coffee in
inhibiting NF-κB activation.
The cyclooxygenase (COX) pathway is responsible for
the conversion of arachidonic acid into prostaglandins;
the most widely recognized mediators of inflammation.
COX-1 and COX-2 are two isoforms of the COX enzyme.
Accumulated evidences indicate that the COX-2 pathway
has been implicated in liver inflammation, matrix remod-
elling, fibrosis progress and development of hepatocellular
carcinoma [82, 83]. Previous data also documented in-
creased expression and enhanced formation of COX-2 in
CCl4-induced liver injury [82–84] which is consistent with
our results where strong immunoreactivity of COX-2 was
detected in liver of CCl4-treated rats. NF-κB is involved in
the regulation of COX-2 gene expression by binding to its
promoter regions and enhancing the COX-2 transcription
[85]. The enhanced activation and translocation of NF-κB
p65 in the present study may explain the increased ex-
pression of COX-2 in CCl4-induced liver injury. Import-
antly, COX-2 inhibition was beneficial in CCl4-induced
fibrosis as it reduces cell growth and triggers apoptosis in
HSCs and exerts antifibrogenic actions [82–84]. It is obvi-
ous from our study that both DFE and DPE down-
regulated the activation of NF-κB and simultaneously sup-
pressed COX-2 expression, suggesting the inhibition of
this proinflammatory pathway may be a potential strategy
for prevention of inflammatory liver injury and fibrogen-
esis. In agreement with our results, Zhang et al. [86]
reported that Ajwa, a variety of date palm Phoenix dactyli-
fera L. is very active as anti-inflammatory and inhibited
both COX-1, COX-2 activity.
The HO-1 plays an important role in various patho-
physiological conditions owing to its antioxidative, anti-
inflammatory, antiapoptosis, and potent cytoprotective
properties [16–20]. Thus, pharmacological modulation
of the HO-1 system may represent an effective and co-
operative strategy to mitigate liver injury. In the current
study, CCl4 induced downregulation of HO-1 expression
(Fig. 10, Panel B) which may contribute to oxidative
stress, inflammatory response and fibrogenesis in hepatic
cells. Co-administration of DFE, DPE or coffee signifi-
cantly ameliorated this reduction, particularly with DFE
and coffee suggesting a new mechanism for their antifi-
brotic action. Previous reports demonstrated that HO-1
induction by coffee is attributed to polyphenolic constitu-
ents, the most abundant form being chlorogenic acid and
caffeic acid. In addition, it has been demonstrated that caf-
feic acid and kahweol, polyphenolic and diterpine constit-
uents of coffee, drastically activated the HO-1 gene with
elevated induction of HO-1 leading to the control of intra-
cellular levels of ROS [55, 56]. Except for the current
study, no data are available concerning the role of DFE or
DPE on the induction HO-1. Future studies are recom-
mended to evaluate which constituents of dates are in-
volved in the HO-1 induction in hepatic cells.
Conclusion
In summary, data from our study indicated that the po-
tential of DFE and DPE to suppress TIMP-1 and -2 ex-
pressions in liver helps to explain, at least in part, the
fibrolytic effect of dates enhancing the degradation of
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ECM and minimizing the collagen deposition. In
addition, our results demonstrated that, the anti-
inflammatory potential of dates is strongly related to the
inhibition of NF-κB translocation, reduced expression of
COX-2 and restoration of HO-1 activity. The antifibrotic
effects of dates could be also associated with reduced
DNA oxidative damage possibly through the elimination
of CCl4-generated free radicals. The present study re-
vealed a clinical potential of date fruits either flesh or
pits for therapeutic antifibrotic applications.
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